By force cdmo gradually become the pharmaceutical enterprises research and development production activities of the optimal solution
Time of Update: 2021-03-06
CDMO's hardware and software capabilities are reflected differently in meeting the core requirements of the two main types of customers of large pharmaceutical companies and innovative small and medium-sized pharmaceutical enterprises.
View point . . . FDA Director: Promote advanced manufacturing to help pharmaceutical product development.
Time of Update: 2020-09-10
partnerships with stakeholders such as American Makes, a national research organization for ingredient manufacturing innovation, BioFab USA, the National Institute for Biopharmaceutical Innovation, and a number of industry organizations and clinical
The development of pharmaceutical manufacturing industry continues to be good, pharmaceutical machine enterprise opportunities have come.
Time of Update: 2020-08-29
has gradually developed from simple imitation to independent research and development innovation stage. , for example, a leading domestic pharmaceutical equipment solid preparation enterprises are currently building high-end pharmaceutical
Pharmaceutical manufacturing revenue continued to pick up, pharmaceutical equipment industry ushered in a good opportunity for development.
Time of Update: 2020-08-11
Pharmaceutical Network Market Analysis: Pharmaceutical manufacturing industry refers to the chemical pharmaceutical industry (including chemical raw materials and chemical agents), Chinese medicine industry (including traditional Chinese medicine
With the digital development of manufacturing industry, how will the pharmaceutical machine enterprises be affected.
Time of Update: 2020-07-27
Pharmaceutical Network Industry Dynamics: Siemens and SAP recently announced a new partnership that will accelerate the global industrial transformation by bringing together their expertise in the industrial sector by integrating complementary
Cinda Bio and Lilly Pharmaceuticals develop an innovative gastric acid regulator (OXM3)
Time of Update: 2020-06-08
Recently, Cinda Bio announced a strategic partnership with Lilly Pharmaceutical ( to jointly promote the development and commercialization of an innovative gastric acid regulatory compound (OXM3) in China.
The core driving force for the future development of pharmaceutical manufacturing: intelligent manufacturing
Time of Update: 2020-02-07
In recent years, many pharmaceutical companies based on the development of intelligent manufacturing, accelerate the pace of transformation and upgrading, the introduction of intelligent manufacturing concepts, and continuously improve the level of production automation, improve product quality.
Flexible manufacturing: opening the "key" to the bottleneck of pharmaceutical equipment development
Time of Update: 2019-09-05
Pharmaceutical Network Market Analysis " "Smart Manufacturing" has become a new global growth point, Germany in the development of industry 4.0, China launched "smart manufacturing 2025." One of the characteristics of intelligent
From September, these new policies and regulations will affect the pharmaceutical manufacturing industry!
Time of Update: 2019-09-03
[pharmaceutical network industry trends] the industry once took September as the four confirmation periods of domestic policies and corporate profits
34 pharmaceutical manufacturers actively apply for suspension of production! Different reasons
Time of Update: 2019-07-29
A large number of pharmaceutical enterprises were ordered to stop production for rectification due to environmental protection problems, and even faced with bankruptcy.
Driven by innovation, "intelligent manufacturing" upgrades China's pharmaceutical equipment
Time of Update: 2019-07-19
It can be seen that more and more pharmaceutical equipment enterprises are improving the degree of innovation of equipment products through innovation and accelerating the high-quality development of the industry.
[one week Jun] after tax inspection, 21 pharmaceutical companies hit the gun again; new regulations
Time of Update: 2019-07-01
This week's highlights: 1
New cooperation mode to support the inheritance and development of traditional Chinese medicine; 2
The urgent need for overseas new
Behind the development of the manufacturing industry in the past 40 years, the pharmaceutical equipment industry in China has taken on a new look
Time of Update: 2019-05-23
Industry insiders pointed out that one of the obvious defects of Chinese pharmaceutical equipment enterprises is the lack of core technology, and the level of domestic pharmaceutical equipment industry needs to be further improved.
Traditional pharmaceutical companies actively embrace artificial intelligence and accelerate new drug research and development
Time of Update: 2019-05-05
[industry trends of pharmaceutical Station] recently, AstraZeneca, a pharmaceutical giant, announced a long-term cooperation with benevolentai, a British artificial intelligence
Green leaf pharmaceutical: layout global development strategy and actively integrate into the tide of innovation era
Time of Update: 2018-11-22
[China Pharmaceutical network enterprise news] in order to thoroughly implement the spirit of the 19th National Congress of the Communist Party of China, summarize and display
CHUANGMEI pharmaceutical actively improves its distribution ability and accelerates its business development
Time of Update: 2017-04-06
CHUANGMEI pharmaceutical is one of the pharmaceutical distributors with distribution network covering South China, Fujian Province and other regions.
Where is the most active research and development direction for domestic pharmaceutical companies?
Time of Update: 2015-07-10
Source: medical economics report 2015-7-10 although there are many diabetes drugs currently used in clinical practice, there are higher clinical requirements, including better
Kangyuan pharmaceutical actively distributes research and development of biological drugs
Time of Update: 2015-06-09
At present, the group is actively distributing biopharmaceutical field through independent research and development and extended M & A, the company said.
China Council for the promotion of drugs and American pharmaceutical research and Manufacturers
Time of Update: 2013-07-12
Source: on the morning of July 11, 2013, China Council for the promotion of drugs and American pharmaceutical research and Manufacturers Association (hereinafter referred